NCT05578417 A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada Status COMPLETED Phase N/A
NCT05576805 A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada Status COMPLETED Phase N/A
NCT05571137 A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada Status COMPLETED Phase N/A
NCT05561647 A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey) Status RECRUITING Phase N/A
NCT05543187 A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) Status COMPLETED Phase PHASE3
NCT05543174 A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS) Status COMPLETED Phase PHASE3
NCT05529992 A Study of Velaglucerase Alfa (VPRIV) in Chinese Children, Teenagers, and Adults With Type 1 Gaucher Disease Status COMPLETED Phase PHASE3
NCT05513586 A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants Status COMPLETED Phase PHASE3
NCT05509569 A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema Status COMPLETED Phase N/A
NCT05494593 A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II) Status WITHDRAWN Phase PHASE4
NCT05489640 A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home Status COMPLETED Phase N/A
NCT05481437 A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma Status RECRUITING Phase N/A
NCT05469802 A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy Adults Status WITHDRAWN Phase PHASE2
NCT05469789 A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05466747 A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema Status WITHDRAWN Phase PHASE4
NCT05460325 A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE) Status COMPLETED Phase PHASE3